课题基金 / 基金详情

VANDERBILT CENTER FOR EDUCATION/RESEARCH ON THERAPEUTICS

VANDERBILT CENTER FOR EDUCATION/RESEARCH ON THERAPEUTICS
范德比尔特治疗学教育/研究中心
批准号:
6556818
负责人:
WAYNE A RAY
金额:
$21.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2002-09-29

项目摘要

项目成果

WAYNE A RAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A Vanderbilt Center for Education and Research in Therapeutics (CERT) is proposed as part of a national collaboration to systematically promote rational pharmacotherapy. The CERTs will work to systematically translate scientific advances into improved clinical outcomes. The theme of the Vanderbilt CERT is Encouraging Rational Pharmacotherapy in Medicaid Managed Care. The Medicaid population is the therapeutic focus because its enrollees are particularly vulnerable to suboptimal pharmacotherapy and that, for a variety of reasons, are underrepresented in extant research. Vulnerable groups include he developing fetus, young children, African-Americans and other minorities, the chronically ill, the elderly, and persons in nursing homes. The Medicaid population also provides an outstanding data source that permits identification of suboptimal pharmacotherapy and evaluation of educational programs. Our focus on managed care emphasizes that an under-recognized determinant of rational pharmacotherapy may be programs and policies implemented by managed care. The goal of the Vanderbilt CERT is to improve pharmacotherapy by combatting three specific threats to rational pharmacotherapy: inadequate knowledge base, suboptimal provider or patient behavior, and counterproductive policies. To this end, the CERT will combine expertise in pharmacoepidemiology, health services research, clinical pharmacology, informatics, biostatististics, and behavioral sciences. The specific aims of the CERT thus are: 1. Improve the knowledge base for rational pharmacotherapy by conducting clinical pharmacologic and pharmacoepidemiologic studies. We propose two pilot studies, one of factors influencing drug penetration of sanctuary sites and another comparing adverse effects of Cox 1 and Cox 2 NSAIDs. 2. Modify suboptimal provider or patient behavior through focused educational programs. 3. Determine the effects of policies on pharmacotherapy and clinical outcomes by conducting rigorous evaluations of program and policy changes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Outcomes of non-vitamin K anticoagulants in atrial fibrillation
Outcomes of non-vitamin K anticoagulants in atrial fibrillation
Antipsychotics and the Risk of Unexpected Death in Children and Youth
Antipsychotics and the Risk of Unexpected Death in Children and Youth
海外基金